Skip to content
value.today
Viva Biotech Holdings logo

Viva Biotech Holdings

1873.HK
$266 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$306 M
Dec-2021 ending year
value.today research
Net income
$42 M
13.7% margin
value.today research
Employees
—

Viva Biotech Holdings in brief

Viva Biotech Holdings is a listed company in the Biotechnology industry, based in China. Its last known market value was $266 M (January 2024); there is no current figure. In the year to Dec 2021 it had sales of $306 M and a net profit of $42 M, about 14 cents of profit for every dollar of sales. Its shares trade under the symbol 1873.HK (HKeX).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Viva Biotech Holdings share price · HKeX (1873.HK)

daily · 38 trading days since 2026
Last close 1.145 HKD (Nov 19, 2026)1 month: -15.8%52-week range 1.130 – 1.830 HKD
$0 M$0 M$1 M$1 M$2 M
DateHighLowCloseChangeVolume
Nov 19, 20261.1551.1301.145-1.7%1.3 M
Nov 18, 20261.1751.1401.1650.0%2.0 M
Nov 17, 20261.2151.1651.165-3.3%4.3 M
Nov 16, 20261.2651.2001.205-3.6%3.4 M
Nov 13, 20261.2951.2451.250-3.5%2.8 M
Nov 12, 20261.3301.2851.295-0.8%1.1 M
Nov 11, 20261.3301.2901.305-1.1%1.2 M
Nov 10, 20261.3551.3201.320+1.1%796,000
Nov 9, 20261.3501.3001.305-1.5%4.6 M
Nov 6, 20261.3551.2801.325-1.5%7.2 M
Nov 5, 20261.3701.2951.345+4.3%3.7 M
Nov 4, 20261.3001.2101.290+6.2%3.6 M
Nov 3, 20261.2501.1901.215-2.8%4.5 M
Nov 2, 20261.2901.2301.2500.0%1.5 M
Oct 30, 20261.3001.2301.250-1.6%3.1 M
Oct 29, 20261.3351.2701.270-4.2%2.7 M
Oct 28, 20261.3401.2601.325+6.9%3.3 M
Oct 27, 20261.2701.2401.240-0.8%3.3 M
Oct 26, 20261.2651.2351.250-2.3%2.6 M
Oct 23, 20261.2901.2301.280-1.5%5.3 M
Oct 22, 20261.3501.2801.300-3.7%6.0 M
Oct 21, 20261.4301.3451.350-0.7%3.9 M
Oct 20, 20261.4101.3201.360+0.4%3.6 M
Oct 16, 20261.4151.3201.355+2.3%4.7 M
Oct 15, 20261.3701.3201.325-3.3%4.2 M
Oct 14, 20261.3951.3451.370-0.4%2.2 M
Oct 13, 20261.4451.3601.375-5.2%5.5 M
Oct 12, 20261.6001.4501.450-6.1%5.5 M
Oct 9, 20261.5901.4351.545+1.6%10.7 M
Oct 8, 20261.7251.5251.520—9.3 M

Prices in HKD from Hong Kong Exchanges (no opening price in its report); the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Viva Biotech Holdings share price statistics

computed nightly from the daily prices
HKeX · 1873.HKClose 1.145 HKD (Nov 19, 2026)
1 day
-1.7%
1 week
-11.6%
1 month
-15.5%
3 months
—
Year to date
—
1 year
—
3 years
—
5 years
—
10 years
—
52-week low 1.130-37.4% from the highhigh 1.830
Highest on record 1.830 HKD (Oct 6, 2026)Volume 3.9 M shares/dayValue traded 5.3 M HKD/dayVolatility 55% (30d)38 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$537 M$1.1 B$1.6 B$2.1 B20202021202220232024

World rank over time

▼ down 8,398 places since 2020
2020-01-01: #8026#8,02620202021-01-01: #5471#5,47120212022-01-07: #9035#9,03520222022-12-25: #13873#13,87320222023-07-30: #13608#13,60820232024-01-05: #16424#16,4242024

Rank in China: #1,715 (Jan 2020) · #1,163 (Jan 2021) · #2,414 (Jan 2022) · #4,001 (Dec 2022) · #3,945 (Jul 2023) · #4,827 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
13.7%
Operating margin
—
Return on equity
7.4%
Liabilities / assets
51.3%

Annual results

Revenue
$306 M
Operating income
—
Net income
$42 M

Dec-2021 ending year

Balance sheet

Total assets
$1.2 B
Total liabilities
$601 M
Total equity
$569 M

Dec-2021 ending year

Mutual funds holding Viva Biotech Holdings#

20 funds hold shares worth $3 M. Since their previous reports 1 added shares and 8 sold, selling $1 M net.
Mutual funds holding Viva Biotech Holdings
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP6.64 M$1 M—<0.01%no changeJul 31, 2026
🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc.3.33 M$0 M—<0.01%−1.6%Jun 30, 2026
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP2.09 M$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust2.12 M$0 M—<0.01%no changeMay 31, 2026
🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP1.07 M$0 M—<0.01%−59%Jul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP984,500$0 M—<0.01%+11%Jul 31, 2026
🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP791,000$0 M—<0.01%−33%Jul 31, 2026
🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc.701,500$0 M—0.01%−10%Jun 30, 2026
🇺🇸 State Street Emerging Markets Enhanced Index PortfolioBrighthouse Investment Advisers, LLC637,000$0 M—<0.01%no changeJun 30, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP427,500$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Equity FundAmerican Century ETF Trust313,500$0 M—<0.01%no changeMay 31, 2026
🇺🇸 World ex U.S. Targeted Value PortfolioDimensional Fund Advisors LP265,500$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP187,500$0 M—<0.01%−60%Jul 31, 2026
🇺🇸 Emerging Markets Sustainability Core 1 PortfolioDimensional Fund Advisors LP172,000$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust166,500$0 M—0.02%no changeMay 31, 2026
🇺🇸 Emerging Markets Targeted Value PortfolioDimensional Fund Advisors LP133,500$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Responsible Emerging Markets Equity ETFAmerican Century ETF Trust54,500$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP48,000$0 M—<0.01%−96%Jul 31, 2026
🇺🇸 SA Emerging Markets Value FundFocus Advisor Solutions, LLC45,500$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Avantis Emerging Markets Value ETFAmerican Century ETF Trust9,000$0 M—<0.01%no changeMay 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 20 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

How Viva Biotech Holdings compares in Biotechnology

  • Revenue$306 M · higher than 82% of 647
  • Net margin13.7% · higher than 81% of 408

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Viva Biotech Holdings🇨🇳$266 M—13.7%—
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
Dec-2021 ending year
Balance sheet:
Dec-2021 ending year
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Viva Biotech Holdings? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Viva Biotech Holdings's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Viva Biotech Holdings? Suggest a correction